-
1
-
-
1642575212
-
A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia
-
DOI 10.1016/j.amjhyper.2003.09.011
-
Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens. 2004; 17:154-160. (Pubitemid 38125133)
-
(2004)
American Journal of Hypertension
, vol.17
, Issue.2
, pp. 154-160
-
-
Qiu, C.1
Luthy, D.A.2
Zhang, C.3
Walsh, S.W.4
Leisenring, W.M.5
Williams, M.A.6
-
2
-
-
84867043178
-
ACOG practice bulletin
-
ACOG Committee on Obstetric Practice. January
-
ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.
-
(2002)
Diagnosis and Management of Preeclampsia and Eclampsia
, Issue.33
-
-
-
3
-
-
0036551051
-
-
American College of Obstetricians and Gynecologists
-
American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 77:67-75.
-
(2002)
Int J Gynaecol Obstet
, vol.77
, pp. 67-75
-
-
-
4
-
-
0036227043
-
Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: A comparative study
-
Topalak O, Saygili U, Soyturk M, Karaca N, Batur Y, Uslu T, Erten O. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study. Gynecol Oncol 2002; 85:108113.
-
(2002)
Gynecol Oncol
, vol.85
, pp. 108113
-
-
Topalak, O.1
Saygili, U.2
Soyturk, M.3
Karaca, N.4
Batur, Y.5
Uslu, T.6
Erten, O.7
-
5
-
-
0036513464
-
Levels of C-reactive protein in pregnant women who subsequently develop preeclampsia
-
Savvidou MD, Lees CC, Parra M, Hingorani AD, Nicolaides KH. Levels of C-reactive protein in pregnant women who subsequently develop preeclampsia. Br J Obstet Gynecol 2002; 109:297-301.
-
(2002)
Br J Obstet Gynecol
, vol.109
, pp. 297-301
-
-
Savvidou, M.D.1
Lees, C.C.2
Parra, M.3
Hingorani, A.D.4
Nicolaides, K.H.5
-
6
-
-
0034755324
-
Obesity and preeclampsia: The potential role of inflammation
-
Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 2001; 98:757-762.
-
(2001)
Obstet Gynecol
, vol.98
, pp. 757-762
-
-
Wolf, M.1
Kettyle, E.2
Sandler, L.3
Ecker, J.L.4
Roberts, J.5
Thadhani, R.6
-
7
-
-
23044493645
-
Association of fibrinogen and C-reactive protein with severity of preeclampsia
-
Aug 1
-
Ustün Y, Engin-Ustün Y, Kamaci M. Association of fibrinogen and C-reactive protein with severity of preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005 Aug 1; 121:154-158.
-
(2005)
Eur J Obstet Gynecol Reprod Biol
, vol.121
, pp. 154-158
-
-
Ustün, Y.1
Engin-Ustün, Y.2
Kamaci, M.3
-
8
-
-
34447290480
-
Maternal serum highly sensitive C-reactive protein in normal pregnancy and preeclampsia
-
Hwang HS, Kwon JY, Kim MA, Park YW, Kim YH. Maternal serum highly sensitive C-reactive protein in normal pregnancy and preeclampsia. Int J Gynaecol Obstet 2007; 98:105-109.
-
(2007)
Int J Gynaecol Obstet
, vol.98
, pp. 105-109
-
-
Hwang, H.S.1
Kwon, J.Y.2
Kim, M.A.3
Park, Y.W.4
Kim, Y.H.5
-
9
-
-
0035208903
-
Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia
-
Teran E, Escudero C, MoyaW, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia. Int J Gynecol Obstet 2001; 75:243-249.
-
(2001)
Int J Gynecol Obstet
, vol.75
, pp. 243-249
-
-
Teran, E.1
Escudero, C.2
Moyaw Flores, M.3
Vallance, P.4
Lopez-Jaramillo, P.5
-
11
-
-
0042167384
-
Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction
-
Tjoa ML, Van Vugt JMG, Go ATTJJ, Blankenstein MA, Oudejans CBM, Van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immun 2003; 59:29-37.
-
(2003)
J Reprod Immun
, vol.59
, pp. 29-37
-
-
Tjoa, M.L.1
Van Vugt, J.M.G.2
Attjj, G.3
Blankenstein, M.A.4
Oudejans, C.B.M.5
Van Wijk, I.J.6
-
12
-
-
33645354831
-
Elevated CA125 level associated with Meigs' syndrome: Case report and review of the literature
-
Morán-Mendoza A, Alvarado-Luna G, Calderillo-Ruiz G, Serrano-Olvera A, López-Graniel CM, Gallardo-Rincón D. Elevated CA125 level associated with Meigs' syndrome: case report and review of the literature. Int J Gynecol Cancer 2006; 16 Suppl 1:315-318.
-
(2006)
Int J Gynecol Cancer
, vol.16
, Issue.SUPPL. 1
, pp. 315-318
-
-
Morán-Mendoza, A.1
Alvarado-Luna, G.2
Calderillo-Ruiz, G.3
Serrano-Olvera, A.4
López-Graniel, C.M.5
Gallardo-Rincón, D.6
-
13
-
-
0034128498
-
CA125 production by peritoneum: In-vitro and in-vivo studies
-
Epiney M, Bertossa C, Weil A, Campana A, Bischof P. CA125 production by peritoneum: in-vitro and in-vivo studies. Hum Reprod 2000; 15:1261-1265.
-
(2000)
Hum Reprod
, vol.15
, pp. 1261-1265
-
-
Epiney, M.1
Bertossa, C.2
Weil, A.3
Campana, A.4
Bischof, P.5
-
14
-
-
0030245748
-
Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125
-
Zeimet AG, Marth C, Offner FA, Obrist P, Uhl-Steidl M, Feichtinger H, Stadlmann S, Daxenbichler G, Dapunt O. Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125. Gynecol Oncol 1996; 62:384-389.
-
(1996)
Gynecol Oncol
, vol.62
, pp. 384-389
-
-
Zeimet, A.G.1
Marth, C.2
Offner, F.A.3
Obrist, P.4
Uhl-Steidl, M.5
Feichtinger, H.6
Stadlmann, S.7
Daxenbichler, G.8
Dapunt, O.9
-
16
-
-
0023627536
-
Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome
-
Jager W, Diedrich K, Wildt L. Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome. Fertil Steril 1987; 48:675-678.
-
(1987)
Fertil Steril
, vol.48
, pp. 675-678
-
-
Jager, W.1
Diedrich, K.2
Wildt, L.3
-
17
-
-
0022623760
-
Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy
-
Halila H, Stenman UH, Seppala M. Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer 1986; 57:1327-1329.
-
(1986)
Cancer
, vol.57
, pp. 1327-1329
-
-
Halila, H.1
Stenman, U.H.2
Seppala, M.3
-
18
-
-
0035063407
-
Maternal serum Ca125 and Ca15-3 antigen levels in normal and pathological pregnancy
-
Bon GG, Kenemans P, Verstraeten AA, Go S, Philipi PA, van Kamp GJ, van Geijn HP, van Vugt JM. Maternal serum Ca125 and Ca15-3 antigen levels in normal and pathological pregnancy. Fetal Diagn Ther 2001; 16:166-172.
-
(2001)
Fetal Diagn Ther
, vol.16
, pp. 166-172
-
-
Bon, G.G.1
Kenemans, P.2
Verstraeten, A.A.3
Go, S.4
Philipi, P.A.5
Van Kamp, G.J.6
Van Geijn, H.P.7
Van Vugt, J.M.8
-
19
-
-
0027153382
-
Tumor markers in hypertensive disorders of pregnancy
-
Schröcksnadel H, Daxenbichler G, Artner E, Steckel-Berger G, Dapunt O. Tumor markers in hypertensive disorders of pregnancy. Gynecol Obstet Invest 1993; 35:204-208.
-
(1993)
Gynecol Obstet Invest
, vol.35
, pp. 204-208
-
-
Schröcksnadel, H.1
Daxenbichler, G.2
Artner, E.3
Steckel-Berger, G.4
Dapunt, O.5
-
20
-
-
0024524895
-
Measurement of CEA, TPA, neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid
-
Lellé RJ, Henkel E, Leinemann D, Goeschen K. Measurement of CEA, TPA, neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid. Gynecol Obstet Invest 1989; 27:137-142.
-
(1989)
Gynecol Obstet Invest
, vol.27
, pp. 137-142
-
-
Lellé, R.J.1
Henkel, E.2
Leinemann, D.3
Goeschen, K.4
|